This podcast is the second in a series of four featuring IBD specialists Drs Anita Afzali, MD, MPH, FACG, AGAF and Nana Bernasko, DNP, CRNP, WHNP-BC. Our moderator for the series is Mr Rick Davis, PA-C. In this episode, our panel of experts review available medication options and their current place in therapy according to recent evidence and guideline recommendations.

Presenters:

Anita Afzali, MD, MPH, FACG, AGAF
Professor of Clinical Medicine
Abercrombie & Fitch Endowed Chair in Inflammatory Bowel Disease
Medical Director, OSU Inflammatory Bowel Disease Center
Program Director, Advanced Inflammatory Bowel Disease Fellowship
Division of Gastroenterology, Hepatology, and Nutrition
The Ohio State University Wexner Medical Center
Columbus, Ohio

Nana Bernasko, DNP, CRNP, WHNP-BC
Assistant Professor
Division of Gastroenterology and Hepatology
Department of Medicine
Penn State University Medical Center
Hershey, Pennsylvania

Richard H. Davis, PA-C
Senior Physician Assistant
Division of Gastroenterology, Hepatology, and Nutrition
University of Florida College of Medicine
Gainesville, Florida

The content in this series was adapted from a live CE program supported by educational grants from Amgen, Ferring Pharmaceuticls, Inc., and the Leona M. and Harry B. Helmsley Charitable Trust.

To access the full program, go to
pce.is/IBD